Patents by Inventor Jenö Szilbereky

Jenö Szilbereky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antiviral and immune stimulant pharmaceutical composition
    Patent number: 9381213
    Abstract: The invention relates to a novel antiviral and immune-simulating pharmaceutical composition, containing as active ingredient 20-85 mass % of a ?-3-polyunsaturated fatty acid ester, in fish oil concentrate containing 20-70 mass % of a 5,8,11,14,17-eicosapentaenic acid ester and a 4,7,10,13,16,19-docosahexaenic acid ester, further 1-lysine of a salt thereof, optionally a zinc salt, selenium or a selenium compound, as well as additives and carrier ingredients.
    Type: Grant
    Filed: November 15, 2005
    Date of Patent: July 5, 2016
    Assignee: SINNEX MUSZAKI FEJLESZTO ES TANACSADO KFT
    Inventors: Jenö Szilbereky, Andrea Jednákovits, Ernöné Koltai, Gyula Orbán, Katalin Bíró
  • Method of enhancing cellular production of molecular chaperone, hydroxylamine derivatives useful for enhancing the chaperone production and the preparation thereof
    Patent number: 7745465
    Abstract: A method of increasing expression of a molecular chaperon by a cell and/or enhancing the activity of a molecular chaperon in cells is provided. The method comprises treating a cell that is exposed to a physiological stress which induces expression of a molecular chaperon by the cell with an effective amount of a certain hydroxylamine derivative to increase the stress. Alternatively, an hydroxylamine derivative can be administrated to a cell before it is exposed to a physiological stress which induces expression of a molecular chaperon by the cell. Preferably, the cell to which an hydroxylamine derivative is administered is an eukaryotic cell. The hydroxylamine derivative corresponds to the formulae (I) or (II). The invention also provides novel hydroxylamine derivatives falling within the scope of the formulae (I) and (II) as well as pharmaceutical and/or cosmetical compositions comprising the said compounds.
    Type: Grant
    Filed: July 10, 2003
    Date of Patent: June 29, 2010
    Assignee: CytRx Corporation
    Inventors: László Vígh, Péter Literáti Nagy, Jenö Szilbereky, László Ürögdi, Andrea Jednákovits, László Jaszlits, Katalin Bíró, Ede Márványos, Mihály Barabás, Erzsébet Hegedüs, László Korányi, Mária Kürthy, Gábor Balogh, Ibolya Horváth, Zsolt Török, Éva Udvardy, György Dormán, Dénes Medzihradszky, Bea Mézes, Eszter Kovács, Ernö Duda, Beatrix Farkas, Attila Glatz
  • N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance
    Patent number: 6649628
    Abstract: N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers, and the addition salts thereof, pharmaceutical compositions containing the same, methods of treating pathological insulin resistance, methods of treating pathological insulin resistance and pathological conditions associated therewith, and methods of treating pathological insulin resistance by simultaneously treating diabetes-induced chronic complications, especially retinopathy, neuropathy and nephropathy, and/or by simultaneously increasing pathologically decreased peripheral neuroregeneration caused by diabetes.
    Type: Grant
    Filed: December 18, 2001
    Date of Patent: November 18, 2003
    Assignee: Biorex Kutato es Fejleszto RT
    Inventors: Maria Kürthy, Katalin Bíró, Károly Nagy, László Ürögdi, Zita Csákai, Jenö Szilbereky, Tamás Mogyorósi, Magdolna Török, András Komáromi, Ede Márványos, Mihály Barabás, Mihályné Kardos, Zoltán Nagy, László Korányi, Melinda Nagy
  • Optically active pyridyl-4h-1,2,4-oxdadiazine derivative and its use in the treatment of vascular diseases
    Patent number: 6384029
    Abstract: The invention relates to (−)-5,6-dihydro-5-(1-piperidinyl)-methyl-3-(3-pyridyl)-4H-1,2,4-oxadiazine to the therapeutical use thereof and to phamaceutical compositions containing the compounds as active ingredient.
    Type: Grant
    Filed: May 15, 2001
    Date of Patent: May 7, 2002
    Assignee: Biorex Kutató Fejlesztö RT.
    Inventors: Andrea Jednákovits, Lászió Ürögdi, Lászió Dénes, István Kurucz, Ede Márványos, Mihály Barabás, Ernö Bácsy, Zsuzsanna Korom, Zoltán Nagy, László Ürge, Jenö Szilbereky, Károly Acsai, Péter Krajcsi, Zita Csákai, Magdolna Török